| Value | ₹425.0 Cr |
|---|
BSE filing, NSE: METROPOLIS. Summary written from the filing by ALFA Finder's alert engine.
Metropolis Healthcare Ltd: key numbers
- Share price
- ₹545.65
- Market cap
- ₹11,320 Cr
- Revenue (annual)
- ₹1,646 Cr
- Net profit (annual)
- ₹190.0 Cr
- P/E (TTM)
- 56.1×Sector 52.8×
- Promoter holding
- 47.82%-1.04% QoQ
- FII holding
- 11.67%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Metropolis Healthcare Ltd
All →Metropolis Healthcare Board Meeting Date
Metropolis Healthcare intimated a board meeting on November 3, 2026 to consider Q2 and half-year unaudited results and possible interim dividend. Trading window is closed October 1 to November 5, 2026.
Metropolis Healthcare Other Announcement
Metropolis Healthcare Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. This disclosure provides details on the company's equity share distribution.
Metropolis Healthcare Employee Stock Options
Metropolis Healthcare allotted 9,516 equity shares under its RSU Plan, 2020. This issuance follows the exercise of vested stock units by employees.
Metropolis Healthcare Other Announcement
Metropolis Healthcare filed the quarterly certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Metropolis Healthcare Business Update
Metropolis Healthcare provided a business update for Q2FY27, reporting 15% Y-o-Y revenue growth driven by increased patient and test volumes alongside improved EBITDA margins.
Metropolis Healthcare Employee Stock Options
Metropolis Healthcare allotted 66,312 equity shares to employees under its RSU Plan, 2020. This exercise follows the vesting of RSUs previously granted to staff.
Other results update announcements
All →Muthoot Finance Results Update
Muthoot Finance's consolidated profit after tax rose 39% year-on-year to ₹6,103 Crore for the half year. Consolidated loan AUM grew 42% to ₹2,09,317 Crore.
Aditya Birla Lifestyle Brands Results Update
ABLBL reported Q2 FY27 revenue up 11% to Rs.2266 Cr and PAT up 126% to Rs.53 Cr. Network expansion added over 100 stores during the quarter.
Advanced Enzyme Technologies Results Update
Advanced Enzyme Technologies issued a press release highlighting unaudited Q2 and half-year FY27 results. Revenue and profit grew year-on-year, with EBITDA and PAT margins reported.
Eveready Industries India Results Update
Eveready Industries reported Q2 and H1 FY27 unaudited results via press release, with consolidated Q2 revenue of Rs.428.2 crore, up 10.7%. The release also covers the Jammu alkaline facility's commercial production and new product launches.
Central Depository Services (India) Results Update
CDSL's Q2 FY27 media release reports consolidated total income up 22% and net profit up 24% year-on-year. It highlights results for the quarter and half year.
Akme Fintrade (India) Results Update
Akme Fintrade's press release shows H1 FY27 PAT up 19% and AUM crossing Rs. 1,000 crore. The unaudited results were approved by the board.